The names on this page are hidden. Create a free account to reveal 5 records a month, or get Independent Sponsor Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.
M• D••••••••• C•••••• I•••
What matters now
- $6.1M to $35.8Mprobable EBITDA
Probable EBITDA $6.1M to $35.8M on revenue of $204.4M to $511M, estimated from 511 employees.
Inside the $1M to $15M EBITDA range most independent sponsors state they buy.
InferenceDFX estimate from headcount on Form 5500, 45% confidence - 34dealability of 100
Why it fits: operating tenure +6.7, 7 years since earliest plan effective date (floor on age); sector demand +10.5, specialty distribution: sponsor demand index 0.70 (anonymised market prior); benefit plans +5, 5 benefit plans on file (a professionalised employer).
The largest contributions to its dealability score, each with the fact it rests on.
DerivedDFX score, 23 Sep 2026 - 73data confidence of 100
How sure the record is: 2 independent sources; latest effective observation 12 Sep 2026; size estimate at 45% confidence.
How much of this page rests on independent sources rather than on our estimates.
Measuredcount of sources and dates on the record
Specialty distribution (Drug druggist wholesale) employer in Las Vegas, NV, with 914 benefit plan participants on its latest filing, and a benefit plan in place since 2020. No website description has been captured yet.
- +12S•••••••••Estimate••• Locked
- +6.7O•••••••••Fact••• Locked
- +5B•••••••••Fact••• Locked
- +10.5S•••••••••Inference••• Locked
- 0P•••••••••Resolved negative
- 0M•••••••••M•••••••••Inference••• Locked
- Probable revenue
- $204M to $511M Estimate
- Probable EBITDA
- $6.1M to $35.8M Estimate
- Workforce proxy
- 914 plan participants
- Estimate computed on
- 511 employees, the headcount the size estimate used
- Method
- employees x sector revenue/employee band x sector EBITDA margin band
- Confidence
- 45%
- +30S•••••••••Fact2 independent sources
- +29.6F••••••••Factlatest effective observation 2026-09-12
- +13.5S•••••••••Estimate••• Locked
- Jan 1, 2023plan year 2023Company transitionFactPlan terminated, sponsor continuesconfidence 50%2 plans marked final; the sponsor filed again the following plan yearDOL EFAST2 Form 5500 datasets efast.dol.gov · last verified Sep 12, 2026
- Every dated event
- Jan 1, 2023Final benefit plan filingFactTransaction preparation••• LockedDOL EFAST2 Form 5500 datasets efast.dol.gov
No named leader on the record yet: the company's site did not list one where we read it.
- Founded
- benefit plan since Jan 1, 2020 (age floor 6 years)
- Ownership
- not observed
- Plans on file
- 5
| Fact | Value | Class | Effective | Source | Evidence |
|---|---|---|---|---|---|
| Active participants | 511 | Fact | 2024-01-01 | DOL EFAST2 Form 5500 datasets | |
| Dba name | PLANET 13 | Fact | 2024-01-01 | DOL EFAST2 Form 5500 datasets | |
| Ebitda band | $21.0M | Estimate | 2026-09-12 | DFX model output (scores, estimates, matches) no URL | ••• Locked |
| Hq location | Las Vegas, NV | Fact | 2024-01-01 | DOL EFAST2 Form 5500 datasets | |
| Naics code | 424210 | Fact | 2024-01-01 | DOL EFAST2 Form 5500 datasets | |
| Plan count | 5 | Fact | 2024-01-01 | DOL EFAST2 Form 5500 datasets | |
| Plan effective date earliest | 2020-01-01 | Fact | 2024-01-01 | DOL EFAST2 Form 5500 datasets | |
| Plan participants | 914 | Fact | 2025-01-01 | DOL EFAST2 Form 5500 datasets | |
| Plan participants | 349 | Fact | 2024-01-01 | DOL EFAST2 Form 5500 datasets | |
| Plan participants | 459 | Fact | 2023-01-01 | DOL EFAST2 Form 5500 datasets | |
| Plan participants | 100 | Fact | 2022-01-01 | DOL EFAST2 Form 5500 datasets | |
| Subsector | Drug druggist wholesale | Fact | 2024-01-01 | DOL EFAST2 Form 5500 datasets | |
| Vertical | Specialty distribution | Fact | 2024-01-01 | DOL EFAST2 Form 5500 datasets |